Subscribe To Our Free Newsletter |
Sun Pharma slips nearly 4% as USFDA issues import alert on Halol facility
For the year ended March 31, 2022, supplies to the US market from the Halol facility accounted for approximately 3 per cent of the company's consolidated revenues.